Elevated serum concentrations of Ang-2 have also been reported for patients with cancers other than CRC, such as non-small-cell lung cancer and melanoma, in which high serum Ang-2 levels correlate with disease stage and poor OS (Park et al, 2007; Helfrich et al, 2009). This evidence concerns the gene ANGPT2 and melanoma.